Assessing the efficacy and safety of hydroxychloroquine as outpatient treatment of COVID-19: a randomized controlled trial

BACKGROUND: Identification of therapies to prevent severe COVID-19 remains a priority. We sought to determine whether hydroxychloroquine treatment for outpatients with SARS-CoV-2 infection could prevent hospitalization, mechanical ventilation or death. METHODS: This randomized controlled trial was c...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartz, Ilan, Boesen, Mari E., Cerchiaro, Graziela, Doram, Craig, Edwards, Brett D., Ganesh, Aravind, Greenfield, Jamie, Jamieson, Scott, Karnik, Vikram, Kenney, Carol, Lim, Rachel, Menon, Bijoy K., Mponponsuo, Kwadwo, Rathwell, Sarah, Ryckborst, Karla J., Stewart, Breanne, Yaskina, Maryna, Metz, Luanne, Richer, Lawrence, Hill, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: CMA Joule Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248582/
https://www.ncbi.nlm.nih.gov/pubmed/34145052
http://dx.doi.org/10.9778/cmajo.20210069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248582/
https://www.ncbi.nlm.nih.gov/pubmed/34145052
http://dx.doi.org/10.9778/cmajo.20210069

Ejemplares similares